269 related articles for article (PubMed ID: 26601997)
1. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
[TBL] [Abstract][Full Text] [Related]
2. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
DeGregorio GA; Singer J; Cahill KN; Laidlaw T
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
[TBL] [Abstract][Full Text] [Related]
3. Current complications and treatment of aspirin-exacerbated respiratory disease.
Cook KA; Stevenson DD
Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
[TBL] [Abstract][Full Text] [Related]
4. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
5. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
[TBL] [Abstract][Full Text] [Related]
6. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.
Stevens WW; Jerschow E; Baptist AP; Borish L; Bosso JV; Buchheit KM; Cahill KN; Campo P; Cho SH; Keswani A; Levy JM; Nanda A; Laidlaw TM; White AA
J Allergy Clin Immunol; 2021 Mar; 147(3):827-844. PubMed ID: 33307116
[TBL] [Abstract][Full Text] [Related]
7. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
Simon RA; Dazy KM; Waldram JD
Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
[TBL] [Abstract][Full Text] [Related]
8. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
9. Aspirin exacerbated respiratory disease: Current topics and trends.
Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
[TBL] [Abstract][Full Text] [Related]
10. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
[TBL] [Abstract][Full Text] [Related]
11. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
[TBL] [Abstract][Full Text] [Related]
12. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data.
San Nicoló M; Högerle C; Gellrich D; Eder K; Pfrogner E; Gröger M
Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881
[TBL] [Abstract][Full Text] [Related]
13. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
O'Brien EK; Jerschow E; Divekar RD
Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
[TBL] [Abstract][Full Text] [Related]
14. Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.
Sehanobish E; Asad M; Barbi M; Porcelli SA; Jerschow E
Front Immunol; 2021; 12():695815. PubMed ID: 34305932
[TBL] [Abstract][Full Text] [Related]
15. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
Rajan JP; Wineinger NE; Stevenson DD; White AA
J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
[TBL] [Abstract][Full Text] [Related]
17. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
Świerczyńska-Krępa M; Sanak M; Bochenek G; Stręk P; Ćmiel A; Gielicz A; Plutecka H; Szczeklik A; Niżankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Oct; 134(4):883-90. PubMed ID: 24767875
[TBL] [Abstract][Full Text] [Related]
18. Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis.
Lee JY; Simon RA
Curr Allergy Asthma Rep; 2006 May; 6(3):183-4. PubMed ID: 16579867
[No Abstract] [Full Text] [Related]
19. Immunomodulatory treatments for aspirin exacerbated respiratory disease.
Moebus RG; Han JK
Am J Rhinol Allergy; 2012; 26(2):134-40. PubMed ID: 22487291
[TBL] [Abstract][Full Text] [Related]
20. The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis.
Williams AN; Woessner KM
Curr Allergy Asthma Rep; 2008 May; 8(3):245-52. PubMed ID: 18589844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
